LifeMD stock is rated a buy with an FY 2026 target price of ~$6, implying over 85% upside from current levels. Click here to ...

ALEXANDRIA, VA, UNITED STATES, January 26, 2026 / EINPresswire.com / — The Alliance for Pharmacy Compounding (APC) today announced a new, exclusive accreditation partnership with Coalition for ...

The California Board of Pharmacy’s (CBP or “Board”) non-resident pharmacy framework is built around licensure, disclosure, ...

Compounded semaglutide - the active ingredient in the blockbuster drugs mixed with other additives - is produced by ...

Focus remains on a health care services business model tied to pharmacy support and patient access; Method centres on a ...

An informational overview examining category context, publicly available service disclosures, and what consumers often ...

Becker’s asked pharmacy executives from hospitals and health systems across the U.S. to share their top 2026 priority for ...

International healthcare leader brings 25+ years of experience in life sciences, transformation and global growth to PCCA UK.

Doubling of VEVYE® Sales Force is On Track, Expansion of IHEEZO® Commercial Footprint to the Office-Based Setting Underway, and Doubling ...

Phase I clinical unit in Secaucus to conduct large scale Phase I and Bioequivalence studies and radiolabeled human AME research.

Many peptides are produced either by compounding pharmacies in the U.S. or by an ever-growing number of factories in China. The most serious users tend to get peptides from the latter for both a wider ...

Shopper News brings you the latest happenings in your community ...